HTGM - HTG Molecular Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 541.91M
Enterprise Value 327.5M
Trailing P/E N/A
Forward P/E 1-3.56
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.04
Price/Book (mrq)2.61
Enterprise Value/Revenue 31.34
Enterprise Value/EBITDA 6-1.85

Trading Information

Stock Price History

Beta (3Y Monthly) 1.94
52-Week Change 3-51.58%
S&P500 52-Week Change 37.06%
52 Week High 35.4600
52 Week Low 31.4400
50-Day Moving Average 31.8380
200-Day Moving Average 32.3063

Share Statistics

Avg Vol (3 month) 3223.73k
Avg Vol (10 day) 3245.83k
Shares Outstanding 528.71M
Float 22.19M
% Held by Insiders 17.75%
% Held by Institutions 151.30%
Shares Short (Jun 28, 2019) 43.47M
Short Ratio (Jun 28, 2019) 415.17
Short % of Float (Jun 28, 2019) 417.24%
Short % of Shares Outstanding (Jun 28, 2019) 412.10%
Shares Short (prior month May 31, 2019) 43.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -80.03%
Operating Margin (ttm)-79.09%

Management Effectiveness

Return on Assets (ttm)-22.63%
Return on Equity (ttm)-69.98%

Income Statement

Revenue (ttm)20.55M
Revenue Per Share (ttm)0.72
Quarterly Revenue Growth (yoy)-23.00%
Gross Profit (ttm)3.99M
EBITDA -14.83M
Net Income Avi to Common (ttm)-16.44M
Diluted EPS (ttm)-0.5770
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.03M
Total Cash Per Share (mrq)0.87
Total Debt (mrq)10.72M
Total Debt/Equity (mrq)66.85
Current Ratio (mrq)6.30
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-16.07M
Levered Free Cash Flow (ttm)-10.06M